Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions.
Hébert PC, Fergusson D, Blajchman MA, Wells GA, Kmetic A, Coyle D, Heddle N, Germain M, Goldman M, Toye B, Schweitzer I, vanWalraven C, Devine D, Sher GD; Leukoreduction Study Investigators.
Hébert PC, et al. Among authors: goldman m.
JAMA. 2003 Apr 16;289(15):1941-9. doi: 10.1001/jama.289.15.1941.
JAMA. 2003.
PMID: 12697796